The U.S. Food and Drug Administration (FDA) has approved an expanded indication for Libtayo® (cemiplimab-rwlc) as an adjuvant treatment to prevent the…..
Researchers from University College London (UCL) and the University of Oxford have unveiled a groundbreaking ultrasound helmet system that can precisely……
The U.S. Food and Drug Administration (FDA) has approved Jascayd (nerandomilast), a novel phosphodiesterase 4 (PDE4) inhibitor for the treatment of IPF…..